Validation Study of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer

Key Points

• Sentinel lymph node biopsy shows improved diagnostic accuracy after neoadjuvant chemotherapy in breast cancer.
• In patients receiving neoadjuvant chemotherapy, the accuracy rate was 85% for sentinel lymph node biopsy.
• Validation study assesses outcomes using pathological analysis in breast cancer after treatment.
• Findings support the integration of this diagnostic technique in clinical practice for better patient management.